F. Gianfagna | Turku Hypertension Center

Latest

Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
Risk prediction of atrial fibrillation and its complications in the community using hs troponin I
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
Cardiac Troponin I and Incident Stroke in European Cohorts: Insights From the BiomarCaRE Project
Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults
Repositioning of the global epicentre of non-optimal cholesterol
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death
Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium
Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium
Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)